Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.
Mar 2011 - Clin. Cancer Res.; 17(6):1078-0432 [PMID:21135147]
[Prins RM] [Soto H] [Konkankit V] [Odesa SK] [Eskin A] [Yong WH] [Nelson SF] [Liau LM]

Dendritic cell vaccines for brain tumors.
Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944973]
[Kim W] [Liau LM]

Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report.
Jul 2006 - Neurosurg Focus; 9(6):1092-0684 [PMID:16817691]
[Liau LM] [Black KL] [Martin NA] [Sykes SN] [Bronstein JM] [Jouben-Steele L] [Mischel PS] [Belldegrun A] [Cloughesy TF]

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.
Aug 2005 - Clin. Cancer Res.; 11(15):1078-0432 [PMID:16061868]
[Liau LM] [Prins RM] [Kiertscher SM] [Odesa SK] [Kremen TJ] [Giovannone AJ] [Lin JW] [Chute DJ] [Mischel PS] [Cloughesy TF] [Roth MD]